The $583,000 four-year research award will aid research using monoclonal antibodies to lower the chances of non-Hodgkin lymphoma relapse, complications
May 14, 2012
The Fred Hutchinson Cancer Research Center's Dr. Andrew Rezvani has received a four-year, $583,000 mentored research scholar grant from the American Cancer Society. The award supports his work in improving outcomes for patients who receive blood and bone marrow transplants to treat non-Hodgkin lymphoma.
$195,000 career development award propels T-cell lymphoma research
Jan. 11, 2010
Dr. Elizabeth Budde, a researcher in the Fred Hutchinson Cancer research Center Clinical Research Division’s Press Lab, received a three-year, $195,000 career development award from the Leukemia & Lymphoma Society to further her work using immunotherapy to treat non-Hodgkin’s lymphoma.
Brian Till, research associate, studies mantle cell lymphoma
Sept. 21, 2009
Dr. Brian Till, of the Fred Hutchinson Cancer Research Center's Clinical Research Division, was among five early career researchers chosen by the Southwest Oncology Group to attend the group’s 2009 Young Investigator Training Course. The three-day workshop, which took place last week in Seattle, provided intensive training in how to design and conduct cancer clinical trials that may involve hundreds of patients at institutions throughout North America.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.